199 related articles for article (PubMed ID: 21864287)
21. Fabrication of chlorambucil loaded graphene- oxide nanocarrier and its application for improved antitumor activity.
Singh G; Nenavathu BP; Imtiyaz K; Moshahid A Rizvi M
Biomed Pharmacother; 2020 Sep; 129():110443. PubMed ID: 32593130
[TBL] [Abstract][Full Text] [Related]
22. Controlled release of doxorubicin from graphene oxide based charge-reversal nanocarrier.
Zhou T; Zhou X; Xing D
Biomaterials; 2014 Apr; 35(13):4185-94. PubMed ID: 24513318
[TBL] [Abstract][Full Text] [Related]
23. Delivery of paclitaxel using PEGylated graphene oxide as a nanocarrier.
Xu Z; Zhu S; Wang M; Li Y; Shi P; Huang X
ACS Appl Mater Interfaces; 2015 Jan; 7(2):1355-63. PubMed ID: 25546399
[TBL] [Abstract][Full Text] [Related]
24. Exceedingly Higher co-loading of Curcumin and Paclitaxel onto Polymer-functionalized Reduced Graphene Oxide for Highly Potent Synergistic Anticancer Treatment.
Muthoosamy K; Abubakar IB; Bai RG; Loh HS; Manickam S
Sci Rep; 2016 Sep; 6():32808. PubMed ID: 27597657
[TBL] [Abstract][Full Text] [Related]
25. Natural and synthetic polymer for graphene oxide mediated anticancer drug delivery-A comparative study.
Deb A; R V
Int J Biol Macromol; 2018 Feb; 107(Pt B):2320-2333. PubMed ID: 29055699
[TBL] [Abstract][Full Text] [Related]
26. Dual Drug Loaded Potassium-contained Graphene Oxide as a Nanocarrier in Cocktailed Drug Delivery for the Treatment of Human Breast Cancer.
Tiwari H; Karki N; Tewari C; Pandey N; Rana A; Rana S; Pal M; Sahoo NG
Curr Drug Deliv; 2023; 20(7):943-950. PubMed ID: 35611774
[TBL] [Abstract][Full Text] [Related]
27. Pectin-conjugated magnetic graphene oxide nanohybrid as a novel drug carrier for paclitaxel delivery.
Hussien NA; Işıklan N; Türk M
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):264-273. PubMed ID: 29298530
[TBL] [Abstract][Full Text] [Related]
28. Tracking the intracellular drug release from graphene oxide using surface-enhanced Raman spectroscopy.
Huang J; Zong C; Shen H; Cao Y; Ren B; Zhang Z
Nanoscale; 2013 Nov; 5(21):10591-8. PubMed ID: 24057012
[TBL] [Abstract][Full Text] [Related]
29. PEGylated graphene oxide/Fe3O4 nanocomposite: Synthesis, characterization, and evaluation of its performance as de novo drug delivery nanosystem.
Jafarizad A; Taghizadehgh-Alehjougi A; Eskandani M; Hatamzadeh M; Abbasian M; Mohammad-Rezaei R; Mohammadzadeh M; Toğar B; Jaymand M
Biomed Mater Eng; 2018; 29(2):177-190. PubMed ID: 29457592
[TBL] [Abstract][Full Text] [Related]
30. Receptor-targeted, drug-loaded, functionalized graphene oxides for chemotherapy and photothermal therapy.
Thapa RK; Choi JY; Poudel BK; Choi HG; Yong CS; Kim JO
Int J Nanomedicine; 2016; 11():2799-813. PubMed ID: 27358565
[TBL] [Abstract][Full Text] [Related]
31. Assessing biocompatibility of graphene oxide-based nanocarriers: A review.
Kiew SF; Kiew LV; Lee HB; Imae T; Chung LY
J Control Release; 2016 Mar; 226():217-28. PubMed ID: 26873333
[TBL] [Abstract][Full Text] [Related]
32. Folic acid-grafted bovine serum albumin decorated graphene oxide: An efficient drug carrier for targeted cancer therapy.
Ma N; Liu J; He W; Li Z; Luan Y; Song Y; Garg S
J Colloid Interface Sci; 2017 Mar; 490():598-607. PubMed ID: 27923144
[TBL] [Abstract][Full Text] [Related]
33. Carboxymethyl chitosan-mediated synthesis of hyaluronic acid-targeted graphene oxide for cancer drug delivery.
Yang H; Bremner DH; Tao L; Li H; Hu J; Zhu L
Carbohydr Polym; 2016 Jan; 135():72-8. PubMed ID: 26453853
[TBL] [Abstract][Full Text] [Related]
34. Preparation and tumor cell model based biobehavioral evaluation of the nanocarrier system using partially reduced graphene oxide functionalized by surfactant.
Wang Y; Liu K; Luo Z; Duan Y
Int J Nanomedicine; 2015; 10():4605-20. PubMed ID: 26229464
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and characterization of PEG-functionalized graphene oxide as an effective pH-sensitive drug carrier.
Kazempour M; Namazi H; Akbarzadeh A; Kabiri R
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):90-94. PubMed ID: 30663418
[TBL] [Abstract][Full Text] [Related]
36. GO-PEG as a drug nanocarrier and its antiproliferative effect on human cervical cancer cell line.
Bikhof Torbati M; Ebrahimian M; Yousefi M; Shaabanzadeh M
Artif Cells Nanomed Biotechnol; 2017 May; 45(3):568-573. PubMed ID: 27027552
[TBL] [Abstract][Full Text] [Related]
37. Covalent modification of reduced graphene oxide by means of diazonium chemistry and use as a drug-delivery system.
Wei G; Yan M; Dong R; Wang D; Zhou X; Chen J; Hao J
Chemistry; 2012 Nov; 18(46):14708-16. PubMed ID: 23018420
[TBL] [Abstract][Full Text] [Related]
38. Graphene oxide-based magnetic fluorescent hybrids for drug delivery and cellular imaging.
Gao Y; Zou X; Zhao JX; Li Y; Su X
Colloids Surf B Biointerfaces; 2013 Dec; 112():128-33. PubMed ID: 23973670
[TBL] [Abstract][Full Text] [Related]
39. Functionalized graphene oxide as a nanocarrier for dual drug delivery applications: The synergistic effect of quercetin and gefitinib against ovarian cancer cells.
Tiwari H; Karki N; Pal M; Basak S; Verma RK; Bal R; Kandpal ND; Bisht G; Sahoo NG
Colloids Surf B Biointerfaces; 2019 Jun; 178():452-459. PubMed ID: 30921680
[TBL] [Abstract][Full Text] [Related]
40. Targeted delivery of SNX-2112 by polysaccharide-modified graphene oxide nanocomposites for treatment of lung cancer.
Liu X; Cheng X; Wang F; Feng L; Wang Y; Zheng Y; Guo R
Carbohydr Polym; 2018 Apr; 185():85-95. PubMed ID: 29421063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
